New-ATE-Logo2019 (1)


New Generation Planova™ S20N

Demonstrates Robust Performance

for Multi-Specific Antibodies



Jessica Waller, PhD
Principal Scientist Biologics Development,
Bristol Myers Squibb
Jessica received her PhD in physiology and neurobiology from the University of Connecticut and a bachelor's degree in biology from Stockton University. She has over seven years experience with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb. She continues to play key roles supporting early and late stage portfolio products serving as a downstream purification lead for bispecific assets and managing cross-functional collaborations.